← All Skye Bioscience, INC filings

Skye Bioscience, INC Form 4 insider transactions

NASDAQ
SKYE
Skye Bioscience, INC
Form 4: Skye Bioscience CFO Kaitlyn Arsenault Reports Stock and Option Awards
Kaitlyn Arsenault, CFO of Skye Bioscience, reports the acquisition of restricted stock units and stock options based on performance milestones and time-based vesting.
NASDAQ
SKYE
Skye Bioscience, INC
Form 4: Skye Bioscience CEO Punit Dhillon Receives Stock Options and Restricted Stock Units
Skye Bioscience CEO Punit Dhillon was granted stock options and restricted stock units (RSUs) tied to market capitalization and acquisition milestones.